ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it has extended its drug discovery and develop…
Author: The Medical News
Photon etc. announces the launch of IRIS, an innovative Retinal Hyperspectral Imaging system
Targeting the emergent field of hyperspectral retinal imaging, Photon etc. is proud to launch IRIS™, a new device for non-invasive localization of biomolecules in the eye fundus. Based on a custom-made mydriatic retinal camera and Photon etc.’s Tun…
Dompé enters definitive agreement to acquire Anabasis
Dompé, one of Italy’s leading biopharmaceutical companies, announced today that it has entered into a definitive agreement to acquire 100% of Anabasis Srl, a privately held Italian research and development biopharmaceutical company, focused on ocular …
Wolters Kluwer, APAO launch Asia-Pacific Journal of Ophthalmology
Wolters Kluwer Health and the Asia-Pacific Academy of Ophthalmology (APAO) are pleased to announce the launch of the Asia-Pacific Journal of Ophthalmology.
Mobius selects The Apothecary Shops as distribution partner for Mitosol Kit for Ophthalmic Use
Apothecary Shop Wholesale, Inc., an affiliate of The Apothecary Shops Specialty Pharmacies, has received exclusive distribution rights from Mobius Therapeutics, LLC for its new drug Mitosol (mitomycin for solution) 0.2 mg/vial Kit for Ophthalmic Use.
UH’s Eye Institute receives $5M Elisabeth Severance Prentiss Foundation gift
The Elisabeth Severance Prentiss Foundation again has demonstrated its commitment to University Hospitals (UH) with a $5 million gift for the Eye Institute. The gift will honor the late Benjamin L. Millikin, MD, husband of Julia Severance and the grand…
WSU’s novel gene-therapy for blindness receives $250,000 FFB grant
Technology to restore vision through the use of a component of green algae – developed by a Wayne State University professor and scientific director of the Ligon Research Center of Vision at the Kresge Eye Institute – has attracted additional funding f…
Aganirsen demonstrates significant activity in two models of wet AMD, ischemic retinopathy
Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, today announced the publication of data demonstrating the significant activity of aganirsen (GS-101, eye drops) in two important models of retinal ne…
Third patient dosed in Phase 1/2 SMD trial using RPE cells derived from hESCs
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today the dosing of third patient in its Phase 1/2 trial for Stargardt’s macular dystrophy (SMD) using retinal pigment epithelial (RPE) cells derived from human e…
Merck’s ZIOPTAN for reducing elevated IOP receives FDA approval
Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration has approved ZIOPTANTM (tafluprost ophthalmic solution) 0.0015%, the first preservative-free prostaglandin analog ophthalmic solution.
Regeneron reports total revenues of $123.0M for fourth quarter 2011
Regeneron Pharmaceuticals, Inc. today announced financial and operating results for the fourth quarter and full year 2011 and provided an update on development programs.
Genomics pioneer to present at ARVO 2012 meeting
The Association for Research in Vision and Ophthalmology is pleased to welcome J. Craig Venter as the keynote speaker at the opening session of ARVO 2012 on Sunday, May 6 in Fort Lauderdale, Fla. Venter’s presentation is entitled “From Reading to Writi…
Readministration of gene therapy improves vision in three patients with LCA
Gene therapy for congenital blindness has taken another step forward, as researchers further improved vision in three adult patients previously treated in one eye.
AFER congratulates the first Genentech AMD Fellowship recipients
ARVO Foundation for Eye Research (AFER) congratulates the first AFER/Genentech Age-related macular Degeneration Fellowship recipients – Balamurali K. Ambati, MD, PhD, and Stephen H. Tsang, MD, PhD. Each received $40,000 to support their age-related mac…
Indoco, DSM sign agreement for commercial cooperation for eight APIs
Royal DSM N.V., today announced the signing of an agreement with Indoco Remedies Limited, Mumbai, India, for commercial cooperation for eight Active Pharmaceutical Ingredients (APIs). The alliance came into effect in January 2012.
Circadian’s VGX-100 human antibody improves corneal graft survival
Circadian Technologies Limited announced today the publication of data in the scientific journal, Investigative Ophthalmology & Visual Science (IOVS), showing that VEGF-C expression is markedly up-regulated in corneal graft rejection.
Mass. Eye and Ear cornea specialist wins RPB Senior Scientific Investigator Award
Research to Prevent Blindness (RPB) has granted Massachusetts Eye and Ear Infirmary cornea specialist James Chodosh, M.D., M.P.H., a $150,000 Senior Scientific Investigator Award. RPB Senior Scientific Investigator Awards support nationally recognized …
Experts comment on successful stem cell therapy for blindness
According to a new study published in The Lancet, privately funded and led by UCLA and Advanced Cell Technology researchers, two women suffering a progressive form of blindness have shown improved vision.
Stem cells show promise in treating blindness
A medical breakthrough was reported Monday in the journal The Lancet wherein the results of a therapy using human embryonic stem cells in two legally blind patients was described.
Montefiore vision experts encourage public to learn more about glaucoma
January is National Glaucoma Awareness Month. Vision experts at Montefiore Medical Center encourage the public to learn more about this disease, which is the leading cause of preventable blindness in the United States.